Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Anixa Biosciences Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 41 | 45 | +4 |
| Shares | 3.30M | 3.27M | −36.0K (−1.1%) |
| Value | $9.05M | $10.0M | +$942.3K (+10.4%) |
New holders (11)
Institutions that held Anixa Biosciences Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gemmer Asset Management LLC | 35,000 | $107.0K | 0.02% |
| Charles Schwab Investment Management Inc | 24,216 | $75.0K | 0.00% |
| Citadel Advisors LLC | 24,294 | $74.0K | 0.00% |
| LPL Financial LLC | 21,888 | $67.0K | 0.00% |
| CPWM, LLC | 20,000 | $61.0K | 0.01% |
| Susquehanna International Group, LLP | 17,789 | $54.0K | 0.00% |
| Virtu Financial LLC | 14,738 | $45.0K | 0.00% |
| Acadian Asset Management LLC | 8,675 | $27.0K | 0.00% |
| Venture Visionary Partners LLC | 450 | $1.38K | 0.00% |
| Financial Synergies Wealth Advisors, Inc. | 100 | $306 | 0.00% |
| CWM, LLC | 98 | $0 | 0.00% |
Sold out (7)
Institutions that held Anixa Biosciences Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Marshall Wace, LLP | 28,923 | $80.0K |
| Two Sigma Advisers, LP | 14,438 | $40.0K |
| Goldman Sachs Group Inc | 13,080 | $36.0K |
| Ameriprise Financial Inc | 12,400 | $34.0K |
| Strategic Asset Management, LLC | 3,700 | $10.0K |
| Accel Wealth Management | 1,250 | $3.00K |
| Investors Research Corp | 8 | $0 |